July 2005
Organizational Barriers to Physician Participation in Cancer Clinical Trials
ByCarol P. Somkin, PhD,Andrea Altschuler, PhD,Lynn Ackerson, PhD,Ann M. Geiger, PhD,Sarah M. Greene, MPH,Judy Mouchawar, MD, MPH,Joan Holup, MA,Louis Fehrenbacher, MD,Andrew Nelson, MPH,Andrew Glass, MD,Jonathan Polikoff, MD,Sigrid Tishler, MD,Carolyn Schmidt, RN,Terry Field, DSc,Edward Wagner, MD, MPH
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention
5
